Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Master Trial for Advanced Cancers With Rapid Evaluation of Molecular & Immune Status for Stratified Immunotherapies in Oncology

NCT07431073 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07431073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07431073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Master Trial for Advanced Cancers With Rapid Evaluation of Molecular & Immune Status for Stratified Immunotherapies in Oncology
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Recruiting
Start date
August 21, 2026
Completion date
January 31, 2034
Enrollment
275 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced / metastatic solid tumors, advanced malignancy